Product logins

Find logins to all Clarivate products below.


Blog: Biopharma

Here you will find relevant articles and insight into all Clarivate related products and news.

Tracking the mid-year momentum of the 2026 Drugs to Watch Tracking the mid-year momentum of the 2026 Drugs to Watch
Blog July 8, 2026
Tracking the mid-year momentum of the 2026 Drugs to Watch
Biopharma Biotech Clinical trials
BioWorld: celebrating recognition, reaffirming our mission BioWorld: celebrating recognition, reaffirming our mission
Blog July 1, 2026
BioWorld: celebrating recognition, reaffirming our mission
Biopharma Dealmaking M&A
Navigating global risk in the pharmaceutical supply chain Navigating global risk in the pharmaceutical supply chain
Blog June 26, 2026
Navigating global risk in the pharmaceutical supply chain
Biopharma CMC Commercialization
Bringing oncology medicines to patients faster: How Clarivate R&D Consulting supports every step to approval Bringing oncology medicines to patients faster: How Clarivate R&D Consulting supports every step to approval
Blog June 24, 2026
Bringing oncology medicines to patients faster: How Clarivate R&D Consulting supports every step to approval
ADC Biopharma Biotech
From complexity to clarity: Why patient-centered communication matters From complexity to clarity: Why patient-centered communication matters
Blog June 24, 2026
From complexity to clarity: Why patient-centered communication matters
Biopharma Biotech Commercialization
The rise of the AI analyst: How agentic AI will reshape life sciences consulting The rise of the AI analyst: How agentic AI will reshape life sciences consulting
Blog June 24, 2026
The rise of the AI analyst: How agentic AI will reshape life sciences consulting
Europe looks to shore up global competitiveness with the E.U. Biotech Act Europe looks to shore up global competitiveness with the E.U. Biotech Act
Blog June 22, 2026
Europe looks to shore up global competitiveness with the E.U. Biotech Act
Biopharma Biotech Business Development
The competitive intelligence workflow problem in pharma: a diagnostic framework The competitive intelligence workflow problem in pharma: a diagnostic framework
Blog June 12, 2026
The competitive intelligence workflow problem in pharma: a diagnostic framework
Biopharma Business Development Dealmaking

Biopharma

Increasing your likelihood of success in dealmaking discussions Increasing your likelihood of success in dealmaking discussions
Blog October 17, 2024
Increasing your likelihood of success in dealmaking discussions
Beyond animal testing: the rise of organs-on-chips technology Beyond animal testing: the rise of organs-on-chips technology
Blog October 7, 2024
Beyond animal testing: the rise of organs-on-chips technology
Biotech financing’s rebound: How high will it go? Biotech financing’s rebound: How high will it go?
Blog September 17, 2024
Biotech financing’s rebound: How high will it go?
Early diagnosis in Alzheimer’s disease: A first step towards better care Early diagnosis in Alzheimer’s disease: A first step towards better care
Blog September 11, 2024
Early diagnosis in Alzheimer’s disease: A first step towards better care
After loss of exclusivity, small-molecule generics bite quick and hard, while biologics remain resilient After loss of exclusivity, small-molecule generics bite quick and hard, while biologics remain resilient
Blog August 28, 2024
After loss of exclusivity, small-molecule generics bite quick and hard, while biologics remain resilient
CMS enters drug price negotiation arena in sea change for industry CMS enters drug price negotiation arena in sea change for industry
Blog August 20, 2024
CMS enters drug price negotiation arena in sea change for industry
Beyond transparent pricing: decoding the strategies of major PBMs Beyond transparent pricing: decoding the strategies of major PBMs
Blog August 7, 2024
Beyond transparent pricing: decoding the strategies of major PBMs
Perceptions of pharmaceutical industry affiliates on the New Active Substance Work-Sharing Initiative of the Access Consortium Perceptions of pharmaceutical industry affiliates on the New Active Substance Work-Sharing Initiative of the Access Consortium
Blog July 8, 2024
Perceptions of pharmaceutical industry affiliates on the New Active Substance Work-Sharing Initiative of the Access Consortium
These seven ADC makers are developing therapies that show promise for hard-to-treat cancers These seven ADC makers are developing therapies that show promise for hard-to-treat cancers
Blog June 17, 2024
These seven ADC makers are developing therapies that show promise for hard-to-treat cancers
Indication Expansion: Pioneering new uses for existing cancer drugs Indication Expansion: Pioneering new uses for existing cancer drugs
Blog May 31, 2024
Indication Expansion: Pioneering new uses for existing cancer drugs